上海翔港包装科技股份有限公司 关于为控股子公司提供担保的进展公告 证券代码：603499 证券简称：翔港科技 公告编号：2025-018 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要提示： 被担保人名称及是否为上市公司关联人： 被担保人久塑科技（上海）有限公司（以下简称"久塑科技"）为上海翔港包装 科技股份有限公司（以下简称"公司"）的控股子公司，不属于公司的关联人。 本次担保金额及已实际为其提供的担保余额： （一）本次担保的基本情况 2025 年 7 月 22 日，公司与上海银行股份有限公司上海自贸试验区分行签署了 《最高额保证合同》，为久塑科技在该银行的银行授信等业务项下具体合同所形成债 权提供连带责任保证。 （二）内部决策程序 公司于 2025 年 4 月 24 日召开第四届董事会第五次会议、于 2025 年 5 月 22 日 召开 2024 年年度股东大会，审议通过《关于申请 2025 年度综合授信额度及提供担 保的议案》，同意公司为全资子公司、控股子公司提供预计不超过 50,000 万元的担 保额度。具 ...

Investment Rating - The report maintains a positive outlook on the cosmetics and medical beauty industry, indicating a "Buy" recommendation for several companies within the sector [2][14]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Beauty Care Index rising by 1.5% from July 4 to July 11, 2025, which is below the market average [3][5]. - The introduction of new products in the regenerative medicine sector, particularly in the "童颜针" (youthful needle) category, is expected to enhance consumer interest and expand the market [2][8]. - The report highlights strong anticipated earnings growth for several key companies in the cosmetics sector for the second quarter of 2025, with notable increases in revenue and net profit for brands like 上美股份 (Shangmei), 丸美股份 (Marubi), and 珀莱雅 (Proya) [9][10][11]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market, with specific indices showing varied performance, such as the Shenwan Cosmetics Index increasing by 2.6% [3][5]. - The report notes that the demand for cosmetics is recovering, with a 4.1% year-on-year increase in retail sales for the first five months of 2025 [19][20]. Company Performance - 上美股份 (Shangmei) is expected to see a revenue increase of 16% and a net profit increase of 25% in the first half of 2025 [10]. - 丸美股份 (Marubi) anticipates a 22% revenue growth and a 28% increase in net profit for the second quarter of 2025 [10]. - 珀莱雅 (Proya) is projected to achieve a 10% revenue growth and a 15% increase in net profit for the second quarter of 2025 [10]. - 毛戈平 (Mao Geping) expects a significant revenue increase of 38% and a net profit increase of 35% in the first half of 2025 [10]. - 若羽臣 (Ruoyuchen) forecasts a remarkable 70% revenue growth and a 75% increase in net profit for the second quarter of 2025 [10]. Market Trends - The report emphasizes the ongoing trend of domestic brands gaining market share, with national brands occupying five of the top ten positions in the skincare market [32]. - The regenerative medicine sector is expanding, with new products enhancing consumer engagement and market growth potential [2][8]. Investment Recommendations - The report recommends focusing on companies with strong brand matrices and high growth potential, such as 上美股份 (Shangmei), 珀莱雅 (Proya), and 丸美股份 (Marubi) [14]. - It suggests monitoring companies that leverage e-commerce and social media platforms effectively, such as 若羽臣 (Ruoyuchen) and 毛戈平 (Mao Geping) [14].

Group 1 - A-share market is experiencing a wave of positive earnings forecasts, with 83 out of 107 companies predicting better-than-expected results, accounting for nearly 80% [1] - Among the companies, 61 are expected to report net profits exceeding 100 million yuan, representing nearly 60% of the total [1] - Notable performers include Industrial Fulian, Lixun Precision, Xinhecheng, and Yun Aluminum, all of which are expected to report net profits exceeding 1 billion yuan [1] Group 2 - Industrial Fulian anticipates a net profit of over 12 billion yuan for the first half of the year, a year-on-year increase of nearly 40%, driven by strong growth in cloud computing and AI server businesses [1] - Lixun Precision expects a profit range of 6.475 billion to 6.745 billion yuan, reflecting a year-on-year growth of 20% to 25% [1] - Xinhecheng forecasts a net profit between 3.3 billion and 3.75 billion yuan, with a year-on-year increase of 50% to 70%, mainly due to rising sales and prices of vitamins [1] Group 3 - 24 companies are predicting a year-on-year net profit increase of over 100%, with Huayin Power expecting a staggering increase of 3600% to 4.423 billion yuan [3] - Other companies like Shen Shen Fang A and Saint Farm are also projecting significant profit increases, with some exceeding 400% [3] - The average stock price of companies that have released earnings forecasts has risen by 27.03% this year, significantly outperforming the market [3] Group 4 - Financing activities have accelerated towards companies with positive earnings forecasts, with 49 companies experiencing net capital inflows [3] - Notably, Xiaoshangpin City has received a net capital inflow of 373 million yuan since July, with an expected net profit growth of over 12% [3] - Overall, despite macroeconomic challenges, leading companies are achieving stable growth due to their core competitiveness [3]

Group 1 - Longte Intelligent's wholly-owned subsidiary plans to establish a private equity investment fund focusing on low-altitude economy and embodied intelligence industry chain with a total investment of 15 million RMB [1] - Huadian Technology signed significant contracts totaling approximately 5.567 billion RMB, which includes design supply and construction contracts for the Nusantara project [2] - Shanghai Xiba plans to participate in the auction for Yuyuan Rare Earth's lithium sulfide business assets to promote development in the new energy sector [3] Group 2 - Lens Technology has set the final price for its H-share issuance at 18.18 HKD per share, with expected listing on July 9, 2025 [4] - Yiling Pharmaceutical received approval for clinical trials of its new drug "G201-Na capsule," aimed at controlling ovulation in assisted reproductive technology [5] - Chendian International announced that the adjustment of the time-of-use electricity pricing mechanism will have a slight impact on its electricity business revenue, with a preliminary estimate of an increase of 382,000 RMB [6] Group 3 - Ruiskanda's chairman and general manager are under criminal coercive measures for suspected violations related to information disclosure [7] - Changhong High-Tech is planning to acquire 100% equity of Guangxi Changke New Materials Co., Ltd., with stock suspension expected for up to 10 trading days [8] Group 4 - Aerospace Engineering is expected to win a project worth 2.392 billion RMB [9] - Several companies, including Xianggang Technology and Yinglian Co., are forecasting significant increases in net profits for the first half of the year, with growth rates ranging from 185% to 478% [10]

Group 1: Company Performance - Wanwei High-tech expects a net profit of 235 million to 265 million yuan for the first half of 2025, representing a year-on-year increase of 81.34% to 104.48% [1] - Jin Guan Electric has won bids for projects from Southern Power Grid and Guangxi Power Grid, with a total bid amount of approximately 42.81 million yuan, accounting for 5.76% of the company's 2024 revenue [2] - Ankai Bus reported a June vehicle sales increase of 37.88% year-on-year, with a total production of 814 vehicles, a 52.23% increase [4] - Daqin Railway's June cargo transport volume increased by 5.29% year-on-year, totaling 32.42 million tons [5] - Xianggang Technology anticipates a net profit of 75 million to 85 million yuan for the first half of 2025, a year-on-year increase of 410% to 478% [9] - Longxin General expects a net profit of 1.005 billion to 1.12 billion yuan for the first half of 2025, a year-on-year increase of 70.52% to 90.03% [10] - Le Xin Technology forecasts a net profit of 250 million to 270 million yuan for the first half of 2025, a year-on-year increase of 65% to 78% [11] - I-Le Furniture expects a net profit of 80 million to 99 million yuan for the first half of 2025, a year-on-year increase of 76.08% to 117.90% [13] - Shennong Group sold 219,000 pigs in June, generating sales revenue of 385 million yuan [14] - Guohuo Airlines anticipates a net profit of 1.187 billion to 1.267 billion yuan for the first half of 2025, a year-on-year increase of 78.13% to 90.14% [45] Group 2: Industry Developments - The electric power equipment industry is seeing increased project bids, as evidenced by Jin Guan Electric's recent contracts [2] - The automotive industry is experiencing growth, with Ankai Bus reporting significant increases in both production and sales [4] - The railway transportation sector is showing resilience with Daqin Railway's cargo transport volume growth [5] - The pharmaceutical industry is advancing with clinical trial approvals, such as Wanbang's WP107 oral solution for treating myasthenia gravis [6] - The packaging and printing industry is witnessing substantial profit growth, as indicated by Xianggang Technology's performance forecast [9] - The agricultural sector, particularly in pig farming, is maintaining steady sales figures, as shown by Shennong Group's sales data [14]

Group 1 - The company expects to achieve a net profit attributable to shareholders of the parent company for the first half of 2025 between 75 million and 85 million yuan, representing an increase of 60.28 million to 70.28 million yuan compared to the same period last year, which is an increase of 410% to 478% year-on-year [1][2] - The company anticipates a net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, to be between 74 million and 84 million yuan, reflecting an increase of 61.68 million to 71.68 million yuan compared to the same period last year [2] - The previous year's net profit attributable to shareholders of the parent company was 14.72 million yuan, with a total profit of 23.83 million yuan [2] Group 2 - The company completed a capital increase plan on June 11, 2025, distributing 4 additional shares for every 10 shares held, increasing the total share capital to 302,594,390 shares [2] - The earnings per share for the previous year was recalculated to be 0.0507 yuan after the capital increase [2]

[Performance Forecast Summary](index=1&type=section&id=Key%20Content%20Highlights) The company expects significant growth in both net profit attributable to shareholders and net profit after deducting non-recurring gains and losses for the first half of 2025, with attributable net profit projected to increase by 410% to 478% and non-recurring adjusted net profit by 501% to 582% 2025 Semi-Annual Performance Forecast Core Indicators | Indicator | Estimated Amount (RMB) | Year-over-Year Growth | | :--- | :--- | :--- | | Net Profit Attributable to Parent Company Shareholders | RMB 75 million - RMB 85 million | 410% - 478% | | Net Profit After Deducting Non-Recurring Gains and Losses | RMB 74 million - RMB 84 million | 501% - 582% | [Details of Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast%20Status) This performance forecast covers January 1 to June 30, 2025, with preliminary estimates by the company's finance department projecting attributable net profit between RMB 75 million and RMB 85 million, and non-recurring adjusted net profit between RMB 74 million and RMB 84 million, pending auditor review - The performance forecast period is from **January 1, 2025, to June 30, 2025**[3](index=3&type=chunk) 2025 Semi-Annual Performance Forecast (Preliminary Financial Department Estimate) | Indicator | Estimated Amount (RMB) | Year-over-Year Change (RMB) | Year-over-Year Growth Rate | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Parent Company Shareholders | RMB 75 million - RMB 85 million | Increase of RMB 60.2828 million - RMB 70.2828 million | 410% - 478% | | Net Profit After Deducting Non-Recurring Gains and Losses | RMB 74 million - RMB 84 million | Increase of RMB 61.6854 million - RMB 71.6854 million | 501% - 582% | - This performance forecast has **not been audited** by a certified public accountant[3](index=3&type=chunk) [Review of Prior Period Performance](index=1&type=section&id=II.%20Prior%20Period%20Operating%20Performance%20and%20Financial%20Position) This report reviews the financial data for the same period in 2024, noting a net profit attributable to parent company shareholders of RMB 14.7172 million, with prior period earnings per share re-calculated due to a capital reserve to share capital transfer 2024 Semi-Annual Performance Data | Indicator | Amount (RMB) | | :--- | :--- | | Total Profit | RMB 23.8320 million | | Net Profit Attributable to Parent Company Shareholders | RMB 14.7172 million | | Net Profit After Deducting Non-Recurring Gains and Losses | RMB 12.3146 million | | Earnings Per Share | RMB 0.0507 | - Due to the implementation of a **10-for-4 share transfer plan** in June 2025, the prior period's earnings per share have been re-calculated based on the adjusted new share capital of **302,594,390 shares**[5](index=5&type=chunk) [Analysis of Performance Pre-Increase Reasons](index=2&type=section&id=III.%20Primary%20Reasons%20for%20Current%20Period%20Performance%20Pre-Increase) The significant performance pre-increase is primarily attributed to successful market expansion leading to substantial growth in packaging business revenue, enhanced internal operational efficiency and cost control, and the realization of economies of scale from increased sales - Key drivers for the company's performance growth include: - **Market Expansion**: Overall strong performance in the packaging business, leading to significant revenue growth - **Efficiency and Cost Control**: Improved operational efficiency and cost control, enhancing profitability - **Economies of Scale**: Substantial sales growth leading to the realization of scale benefits[5](index=5&type=chunk) [Risk Warning](index=2&type=section&id=IV.%20Risk%20Warning) The company explicitly states that this performance forecast is based on preliminary professional judgment and calculations by the finance department and has not yet been audited by an accounting firm, though no significant uncertainties affecting its accuracy are identified - This performance forecast is a **preliminary calculation** by the company's finance department and is **unaudited**[6](index=6&type=chunk) - The company confirms there are **no significant uncertainties** affecting the accuracy of this performance forecast[6](index=6&type=chunk) [Other Explanatory Matters](index=2&type=section&id=V.%20Other%20Explanatory%20Matters) The company reminds investors that the data in this announcement are preliminary, and the final accurate financial information will be based on the officially disclosed '2025 Semi-Annual Report', urging investors to be aware of investment risks - The final accurate financial data will be based on the company's officially disclosed **'2025 Semi-Annual Report'**, and investors are advised to **exercise caution regarding investment risks**[7](index=7&type=chunk)

Group 1 - The company will hold an investor briefing on June 20, 2025, from 15:00 to 16:00 [1][2] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [1][2] - Key personnel attending the meeting include the Chairman, General Manager, Independent Director, Financial Director, and Board Secretary [2] Group 2 - Investors can submit questions for the briefing from June 13, 2025, to June 19, 2025, by visiting the Roadshow Center website or via the company's email [3] - After the briefing, investors can access the main content and details of the meeting through the Roadshow Center [3]

上海翔港包装科技股份有限公司（以下简称"公司"）已于 2025 年 4 月 26 日 发布公司《2024 年年度报告》、《2025 年一季度报告》，为便于广大投资者更全面深 入地了解公司经营成果、财务状况，公司计划于 2025 年 6 月 20 日（星期五） 15:00-16:00 举行 2024 年度暨 2025 年第一季度业绩说明会，就投资者关心的问题 进行交流。 一、说明会类型 证券代码：603499 证券简称：翔港科技 公告编号：2025-016 上海翔港包装科技股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2025 年 6 月 13 日（星期五）至 6 月 19 日（星期四）16:00 前 登 录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公 司 邮 箱 tangjun@sunglow-tec.com 进行提问。公司将在说明会上对投资者普遍关注的问题 ...

证券代码：603499 证券简称：翔港科技 公告编号：2025-015 上海翔港包装科技股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公 司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配及转增股本以方案实施前的公司总股本216,138,850股为基数，每 股派发现金红利0.20元（含税），以资本公积金向全体股东每股转增0.4股，共计派 发现金红利43,227,770元，转增86,455,540股，本次分配后总股本为302,594,390 股。 公司不存在首发战略配售股份 每股分配比例，每股转增比例 A 股每股现金红利0.20元 每股转增股份0.4股 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 新增无限售条件流通 | 现金红利 | | --- | --- | -- ...